tradingkey.logo
tradingkey.logo
Search

Barinthus Biotherapeutics PLC

BRNS
Add to Watchlist
0.740USD
-0.019-2.50%
Close 09-08 16:00ET
30.23MMarket Cap
LossP/E TTM

BRNS Financials

See Barinthus Biotherapeutics PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
30.23M
Dividend TTM
0.00
P/E TTM
-0.59
EPS TTM
-1.29
Revenue
0.00
Net Profit
-61.07M
ROE
-57.52%
ROA
-44.70%

Barinthus Biotherapeutics PLC Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-0.26/-0.28
Revenue / Forecast
--/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
50.53%-0.26
72.25%-0.14
46.91%-0.27
-74.03%-0.36
-20.74%-0.52
-22.15%-0.49
-14.13%-0.51
43.63%-0.21
30.02%-0.43
16.47%-0.40
21.00%-0.45
---0.37
---0.62
---0.48
---0.57
--0.71
----
----
----
----
----
Revenue
----
----
--0.00
-100.00%0.00
----
--0.00
--0.00
--14.97M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-98.04%334.00K
-96.88%468.00K
--6.46M
32347.37%6.17M
48651.43%17.06M
6885.12%15.02M
----
-99.42%19.00K
-93.15%35.00K
Net Profit
49.91%-10.58M
71.85%-5.53M
46.01%-11.09M
-79.52%-14.57M
-24.77%-21.12M
-26.85%-19.65M
-18.78%-20.54M
42.34%-8.11M
28.87%-16.93M
14.80%-15.49M
18.39%-17.29M
-270.74%-14.07M
-251.67%-23.80M
-800.31%-18.18M
---21.19M
280.86%8.24M
198.53%15.69M
117.00%2.60M
----
-2984.18%-4.56M
-343.90%-15.93M
Net Margin
----
----
----
----
----
----
----
---54.31%
----
----
----
----
---7132.93%
---3893.80%
---327.75%
--69.25%
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
--100.00%
----
----
----
----
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
----
----
----
----
----
Revenue
----
----
--0.00
-100.00%0.00
----
--0.00
--0.00
--14.97M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-98.04%334.00K
-96.88%468.00K
--6.46M
32347.37%6.17M
48651.43%17.06M
6885.12%15.02M
----
-99.42%19.00K
-93.15%35.00K
Operating profit
56.62%-10.12M
70.51%-6.08M
-3.43%-11.56M
-10.86%-10.40M
-27.55%-23.32M
-21.79%-20.60M
44.06%-11.18M
41.76%-9.38M
30.57%-18.29M
21.27%-16.91M
23.23%-19.99M
-313.23%-16.11M
-291.01%-26.34M
-3385.02%-21.48M
---26.04M
236.43%7.55M
181.85%13.79M
110.60%654.00K
----
-287.68%-5.54M
-288.49%-16.84M
Net Profit
49.91%-10.58M
71.85%-5.53M
46.01%-11.09M
-79.52%-14.57M
-24.77%-21.12M
-26.85%-19.65M
-18.78%-20.54M
42.34%-8.11M
28.87%-16.93M
14.80%-15.49M
18.39%-17.29M
-270.74%-14.07M
-251.67%-23.80M
-800.31%-18.18M
---21.19M
280.86%8.24M
198.53%15.69M
117.00%2.60M
----
-2984.18%-4.56M
-343.90%-15.93M
Current assets
-36.99%63.27M
-33.87%72.66M
-38.14%77.79M
-35.55%86.78M
-23.86%100.41M
-23.23%109.88M
-19.86%125.74M
-21.28%134.65M
-28.63%131.88M
-28.67%143.13M
-26.35%156.91M
-21.75%171.06M
-18.35%184.78M
-13.05%200.66M
-6.05%213.04M
-11.12%218.62M
-11.86%226.29M
41.27%230.78M
--226.76M
--245.98M
----
Total current liabilities
-10.23%11.42M
0.21%12.00M
-36.02%10.02M
-28.36%10.80M
-18.37%12.72M
-6.69%11.98M
24.28%15.66M
-18.83%15.07M
28.72%15.59M
7.07%12.84M
2.91%12.60M
32.34%18.57M
-0.45%12.11M
-27.27%11.99M
9.72%12.24M
120.20%14.03M
42.41%12.17M
90.55%16.48M
--11.16M
--6.37M
----
Total assets
-36.79%81.89M
-35.11%92.14M
-38.77%98.17M
-42.13%109.20M
-30.62%129.56M
-28.82%142.00M
-25.26%160.33M
-17.95%188.69M
-24.13%186.75M
-23.81%199.48M
-20.61%214.51M
-16.52%229.97M
-13.66%246.13M
-8.50%261.82M
-3.74%270.20M
7.37%275.48M
9.71%285.06M
71.85%286.12M
--280.71M
--256.57M
----
Total liabilities
-8.57%24.76M
-2.80%25.66M
-20.92%23.88M
-15.70%24.64M
-9.61%27.08M
-3.87%26.40M
9.75%30.19M
-14.95%29.23M
4.51%29.96M
-2.76%27.47M
1.88%27.51M
9.70%34.37M
-5.36%28.67M
-14.37%28.25M
-4.08%27.00M
122.19%31.33M
205.12%30.29M
227.08%32.99M
--28.15M
--14.10M
----
Total equity
-44.25%57.13M
-42.49%66.48M
-42.91%74.29M
-46.97%84.56M
-34.64%102.48M
-32.80%115.59M
-30.41%130.13M
-18.48%159.46M
-27.90%156.79M
-26.35%172.02M
-23.11%187.00M
-19.88%195.60M
-14.64%217.46M
-7.73%233.57M
-3.71%243.20M
0.69%244.15M
1.94%254.77M
61.85%253.14M
--252.56M
--242.47M
----
Net operating income
55.32%-8.09M
77.41%-3.37M
-132.42%-4.24M
41.06%-10.73M
-50.83%-18.11M
-26.05%-14.90M
166.76%13.09M
-62.61%-18.20M
29.20%-12.01M
-272.46%-11.82M
-72.82%-19.60M
-194.17%-11.19M
-102.04%-16.96M
51.76%-3.17M
-42.29%-11.34M
688.90%11.88M
42.61%-8.39M
17.44%-6.58M
-62.82%-7.97M
-134.38%-2.02M
----
Net investment
290.63%61.00K
1200.00%55.00K
100.72%2.00K
495.61%451.00K
83.33%-32.00K
98.38%-5.00K
-281.70%-278.00K
-216.67%-114.00K
93.65%-192.00K
87.71%-308.00K
126.11%153.00K
98.22%-36.00K
-47.18%-3.02M
-129.58%-2.51M
95.19%-586.00K
-1476.56%-2.02M
-916.83%-2.05M
-178.57%-1.09M
-6158.66%-12.19M
-326.67%-128.00K
----
Net financing
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-99.60%2.00K
667.89%837.00K
910.87%465.00K
1178.57%358.00K
-70.22%503.00K
-77.48%109.00K
--46.00K
--28.00K
1162.26%1.69M
5277.78%484.00K
100.00%0.00
-100.00%0.00
-100.13%-159.00K
-99.95%9.00K
-105.56%-1.39M
----

FAQs

What are the current assets of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its current assets were 77.79M, with a year-on-year change of -38.14.

What are the total assets of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its total assets of Barinthus Biotherapeutics PLC were 98.17M, with a year-on-year change of -38.77.

What are the total liabilities of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its total liabilities of Barinthus Biotherapeutics PLC were 23.88M, with a year-on-year change of -20.92.

What is the total equity of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its total equity of Barinthus Biotherapeutics PLC was 74.29M, with a year-on-year change of -42.91.

What is the net operating income of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its net operating income of Barinthus Biotherapeutics PLC was -65.89M, with a year-on-year change of -30.57.

What is the net investment of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its net investment of Barinthus Biotherapeutics PLC was 416.00K, with a year-on-year change of 146.64.

What is the net financing of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its net financing of Barinthus Biotherapeutics PLC was 2.00K, with a year-on-year change of -99.91.

What is the Earnings Per Share (EPS) of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -1.64, with a year-on-year change of -5.60.

What is the net income of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its net income was -66.43M, with a year-on-year change of -8.77.

What is the Return on Equity (ROE) of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its Return on Equity (ROE) was -65.05, with a year-on-year change of -68.72.

What is the Return on Assets (ROA) of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its Return on Assets (ROA) was -51.42, with a year-on-year change of -57.51.

What is the operating profit of Barinthus Biotherapeutics PLC?

According to Barinthus Biotherapeutics PLC's FY2025 earnings report, its operating profit was -65.89M, with a year-on-year change of -30.57.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.